Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling
Authors
Keywords
-
Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 45, Issue 7, Pages 475-493
Publisher
Springer Science and Business Media LLC
Online
2022-06-29
DOI
10.1007/s12272-022-01391-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Experimental Evidence for Diiodohydroxyquinoline-Induced Neurotoxicity: Characterization of Age and Gender as Predisposing Factors
- (2022) Ahmed S. Kamel et al. Pharmaceuticals
- Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/d-galactose Alzheimer’s rat model
- (2022) Weam W. Ibrahim et al. INFLAMMOPHARMACOLOGY
- Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways
- (2021) Noha F. Abdelkader et al. BIOMEDICINE & PHARMACOTHERAPY
- Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride
- (2021) Amir Mohamed Abdelhamid et al. LIFE SCIENCES
- Metformin and trimetazidine ameliorate diabetes-induced cognitive impediment in status epileptic rats
- (2020) Marwan Abd Elbaset Mohamed et al. EPILEPSY & BEHAVIOR
- Treatment of diabetic peripheral neuropathy: a review
- (2020) Maher R. Khdour JOURNAL OF PHARMACY AND PHARMACOLOGY
- Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet–Induced Obese Mice
- (2020) Xiaodong Sun et al. DIABETES
- Empagliflozin protects heart from inflammation and energy depletion via AMPK activation
- (2020) Chintan N. Koyani et al. PHARMACOLOGICAL RESEARCH
- Cognitive enhancing effect of diapocynin in D-galactose-ovariectomy-induced Alzheimer's-like disease in rats: Role of ERK, GSK-3β, and JNK signaling
- (2020) Weam W. Ibrahim et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes
- (2020) Stephanie A. Eid et al. Biology-Basel
- AMPK activation attenuates inflammatory pain through inhibiting NF-κB activation and IL-1β expression
- (2019) Hong-Chun Xiang et al. Journal of Neuroinflammation
- Contributions of mTOR Activation-Mediated Upregulation of Synapsin II and Neurite Outgrowth to Hyperalgesia in STZ-Induced Diabetic Rats
- (2019) Wan-you He et al. ACS Chemical Neuroscience
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Kilohertz high-frequency alternating current blocks nerve conduction without causing nerve damage in rats
- (2019) Dandan Ling et al. Annals of Translational Medicine
- Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway
- (2019) Qingguo Lu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition
- (2019) Nitin A. Das et al. CELLULAR SIGNALLING
- Extracellular Matrix Remodeling and Modulation of Inflammation and Oxidative Stress by Sulforaphane in Experimental Diabetic Peripheral Neuropathy
- (2018) Passant E. Moustafa et al. INFLAMMATION
- Lycium barbarum polysaccharide protects diabetic peripheral neuropathy by enhancing autophagy via mTOR/p70S6K inhibition in Streptozotocin-induced diabetic rats
- (2018) Si-Yang Liu et al. JOURNAL OF CHEMICAL NEUROANATOMY
- Liraglutide ameliorated peripheral neuropathy in diabetic rats: Involvement of oxidative stress, inflammation and extracellular matrix remodeling
- (2018) Passant E. Moustafa et al. JOURNAL OF NEUROCHEMISTRY
- Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
- (2018) Hao Zhou et al. Redox Biology
- Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats
- (2018) Kyung Ae Lee et al. Diabetes & Metabolism Journal
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- L-carnitine ameliorates peripheral neuropathy in diabetic mice with a corresponding increase in insulin‑like growth factor‑1 level
- (2018) Rui Wang et al. Molecular Medicine Reports
- AMPK in microvascular complications of diabetes and the beneficial effects of AMPK activators from plants
- (2018) C.B. Shrikanth et al. PHYTOMEDICINE
- Activation of AMPK is neuroprotective in the oxidative stress by advanced glycosylation end products in human neural stem cells
- (2017) Chien-Hung Lin et al. EXPERIMENTAL CELL RESEARCH
- Neuroprotective effect of nebivolol against cisplatin-associated depressive-like behavior in rats
- (2017) Noha F. Abdelkader et al. JOURNAL OF NEUROCHEMISTRY
- Differential Impact of miR-21 on Pain and Associated Affective and Cognitive Behavior after Spared Nerve Injury in B7-H1 ko Mouse
- (2017) Franziska Karl et al. Frontiers in Molecular Neuroscience
- Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure
- (2017) Milton Packer et al. JAMA Cardiology
- The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels
- (2016) Simon A. Hawley et al. DIABETES
- Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis
- (2016) Pavida Pittayapruek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adenosine Monophosphate-Activated Protein Kinase Abates Hyperglycaemia-Induced Neuronal Injury in Experimental Models of Diabetic Neuropathy: Effects on Mitochondrial Biogenesis, Autophagy and Neuroinflammation
- (2016) Veera Ganesh Yerra et al. MOLECULAR NEUROBIOLOGY
- Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy
- (2015) Alesia Sadosky et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Empagliflozin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus
- (2014) Lesley J. Scott DRUGS
- Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms
- (2014) Troels S Jensen et al. LANCET NEUROLOGY
- The Effect of Angipars on Diabetic Neuropathy in STZ-Induced Diabetic Male Rats: A Study on Behavioral, Electrophysiological, Sciatic Histological and Ultrastructural Indices
- (2014) Nasser Zangiabadi et al. TheScientificWorldJOURNAL
- Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial
- (2013) C. S. Kovacs et al. DIABETES OBESITY & METABOLISM
- ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase
- (2013) Ryan C. Russell et al. NATURE CELL BIOLOGY
- Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes
- (2012) Subir K. Roy Chowdhury et al. BRAIN
- Bradley’s Neurology in Clinical Practice
- (2012) Richard J. Lederman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice
- (2011) Z. Xie et al. DIABETES
- Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
- (2011) R. Grempler et al. DIABETES OBESITY & METABOLISM
- Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury
- (2011) Praveen Anand et al. EUROPEAN JOURNAL OF PAIN
- Date Fruit Extract Is a Neuroprotective Agent in Diabetic Peripheral Neuropathy in Streptozotocin-Induced Diabetic Rats: A Multimodal Analysis
- (2011) Nasser Zangiabadi et al. Oxidative Medicine and Cellular Longevity
- Effect of lacidipine pre-treatment on diabetic neuropathy in rats
- (2010) Janardhan Singh et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Diagnosis and Classification of Diabetes Mellitus
- (2009) DIABETES CARE
- Pathological and protective roles of glia in chronic pain
- (2008) Erin D. Milligan et al. NATURE REVIEWS NEUROSCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now